proxyvotesnow.com

Home › Companies › IMMUNITYBIO INC. › 2023-2024

IMMUNITYBIO INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and IMMUNITYBIO INC.’s Form 8-K, filed 2024-06-12 (Item 5.07 on EDGAR). Page generated 04 October 2026.

  • 12Ballot items
  • 164Asset managers
  • 1,736Fund votes
  • 2024-06-11Meeting date

Proxy season: 2023-2024

Explore IMMUNITYBIO INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by IMMUNITYBIO INC.

These tallies are IMMUNITYBIO INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2024-06-12 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

IMMUNITYBIO INC. — official shareholder meeting results, meeting held 2024-06-11
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Patrick Soon-Shiong, M.D. 556,206,355---- 6,438,67746,894,982 Majority: yes
Elect Director: Cheryl L. Cohen 561,728,022---- 917,01046,894,982 Majority: yes
Elect Director: Richard Adcock 561,327,002---- 1,318,03046,894,982 Majority: yes
Elect Director: Michael D. Blaszyk 561,317,164---- 1,327,86846,894,982 Majority: yes
Elect Director: John Owen Brennan 560,173,170---- 2,471,86246,894,982 Majority: yes
Elect Director: Wesley Clark 560,587,816---- 2,057,21646,894,982 Majority: yes
Elect Director: Linda Maxwell, M.D. 561,368,993---- 1,276,03946,894,982 Majority: yes
Elect Director: Christobel Selecky 561,329,841---- 1,315,19146,894,982 Majority: yes
Elect Director: Barry J. Simon, M.D. 559,237,600---- 3,407,43246,894,982 Majority: yes
Proposal 2: Approval of Amendment to Increase the Number of Shares of Common Stock Authorized for Issuance under the ImmunityBio, Inc. 547,258,25712,472,0682,914,707 --46,894,982 Passed
Proposal 3: Advisory Vote to Approve Named Executive Officer Compensation, or Say-on-Pay. 556,683,3662,530,8583,430,808 --46,894,982 Passed
Proposal 4: Ratification of Appointment of Independent Registered Public Accounting Firm . 606,920,4372,216,896402,681 ---- Majority: yes

Source: IMMUNITYBIO INC., Form 8-K, filed with the SEC on 2024-06-12 — read the filing on EDGAR.

How asset managers voted at the IMMUNITYBIO INC. 2023-2024 meeting

Each item below shows how the 164 asset managers that disclosed a IMMUNITYBIO INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. To approve, on an advisory (non-binding) basis, the compensation of our Named Executive Officers ("Say-on-Pay").

SECTION 14A SAY-ON-PAY VOTESCompany result: Passed

Combines 15 wordings of this item as funds reported it.

99.5% Passed · of votes cast

FOR 99.5%
FOR: 556,683,366AGAINST: 2,530,858

IMMUNITYBIO INC.’s own tally for this item (“Proposal 3: Advisory Vote to Approve Named Executive Officer Compensation, or Say-on-Pay.”): 556,683,366 for, 2,530,858 against — passed, per its Form 8-K filed 2024-06-12 (Item 5.07). Of all 691,567,961 outstanding shares: 80% for, 0.4% against (81% of the company cast a for/against vote).

The 162 asset managers below cast 99.2% of the shares they voted on this item FOR (12,429,685 for, 98,477 against).

FOR 99.2%
FOR: 12,429,685 (99.2%)AGAINST: 98,477 (0.8%)ABSTAIN: 1,000 (0.0%)
Largest asset managers voting on “To approve, on an advisory (non-binding) basis, the compensation of our Named Executive Officers ("Say-on-Pay"” at IMMUNITYBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street3,632,3316,514 00For
JPMorgan1,160,8360 00For
PERCEPTIVE ADVISORS LLC738,4690 00For
Northern Trust676,0480 00For
STIFEL NICOLAUS & CO INC \MO\606,6490 00For
BlackRock529,2800 00For
Putnam480,3980 00For
Charles Schwab278,0420 00For
Vanguard258,0130 00For
WP Trust246,9880 00For
SHEETS SMITH WEALTH MANAGEMENT238,7210 00For
MELLON INVESTMENTS Corp229,5650 00For
Goldman Sachs179,2800 00For
Equitable174,8310 00For
WHITTIER TRUST CO OF NEVADA INC172,9900 00For
PNC BANK, NATIONAL ASSOCIATION160,5340 00For
UBS160,1420 00For
AllianceBernstein154,9300 00For
T. Rowe Price145,1950 00For
Fidelity140,3730 00For
First Trust104,090899 00For
MERIDIAN INVESTMENT COUNSEL INC.96,4330 00For
Lincoln Financial96,3000 00For
John Hancock80,2380 00For
CUMBERLAND ADVISORS INC80,0000 00For

Showing the 25 largest of 162 asset managers. See all 162 in the interactive database.

2. To approve an amendment to the ImmunityBio, Inc. 2015 Equity Incentive Plan to increase the number of shares of the company's common stock authorized for issuance under the plan by 19,900,000 shares.

SECTION 14A SAY-ON-PAY VOTESCompany result: Passed

Combines 6 wordings of this item as funds reported it.

98% Passed · of votes cast

FOR 98%
FOR: 547,258,257AGAINST: 12,472,068

IMMUNITYBIO INC.’s own tally for this item (“Proposal 2: Approval of Amendment to Increase the Number of Shares of Common Stock Authorized for Issuance under the ImmunityBio, Inc.”): 547,258,257 for, 12,472,068 against — passed, per its Form 8-K filed 2024-06-12 (Item 5.07). Of all 691,567,961 outstanding shares: 79% for, 2% against (81% of the company cast a for/against vote).

The 50 asset managers below cast 10% of the shares they voted on this item FOR (328,826 for, 2,837,799 against).

10%AGAINST 90%
FOR: 328,826 (10.4%)AGAINST: 2,837,799 (89.6%)
Largest asset managers voting on “To approve an amendment to the ImmunityBio, Inc. 2015 Equity Incentive Plan to increase the number of shares o” at IMMUNITYBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street1,2101,109,252 00Against
WP Trust246,9880 00For
Vanguard0234,737 00Against
Equitable0174,831 00Against
Putnam0163,954 00Against
Charles Schwab0139,021 00Against
Fidelity0125,732 00Against
First Trust0104,090 00Against
Lincoln Financial096,300 00Against
Amplify ETF Trust77,3240 00For
Principal Exchange-Traded Funds062,115 00Against
BlackRock061,254 00Against
Global X060,060 00Against
ProShares059,512 00Against
ETF Series Solutions058,457 00Against
Northern Trust055,921 00Against
Pacific Life045,046 00Against
Direxion Shares ETF Trust043,064 00Against
FundVantage Trust038,447 00Against
AQR037,334 00Against
Bridge Builder Trust031,546 00Against
John Hancock026,735 00Against
CITY NATIONAL ROCHDALE FUNDS019,210 00Against
Invesco016,711 00Against
Principal016,328 00Against

Showing the 25 largest of 50 asset managers. See all 50 in the interactive database.

3. Election of Directors: Patrick Soon-Shiong, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 556,206,355WITHHELD: 6,438,677

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Patrick Soon-Shiong, M.D.”): 556,206,355 for, 6,438,677 withheld, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 691,567,961 outstanding shares: 80% for, 1.0% withheld (81% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (1,149,584 for, 0 against).

FOR 36%ABSTAIN 64%
FOR: 1,149,584 (36.3%)ABSTAIN: 2,017,041 (63.7%)
Largest asset managers voting on “Election of Directors: Patrick Soon-Shiong, M.D.” at IMMUNITYBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street1,2100 1,109,2520Abstain
WP Trust246,9880 00For
Vanguard234,7370 00For
Equitable174,8310 00For
Putnam00 163,9540Abstain
Charles Schwab139,0210 00For
Fidelity125,7320 00For
First Trust00 104,0900Abstain
Lincoln Financial00 96,3000Abstain
Amplify ETF Trust00 77,3240Abstain
Principal Exchange-Traded Funds00 62,1150Abstain
BlackRock61,2540 00For
Global X60,0600 00For
ProShares00 59,5120Abstain
ETF Series Solutions00 58,4570Abstain
Northern Trust00 55,9210Abstain
Pacific Life45,0460 00For
Direxion Shares ETF Trust00 43,0640Abstain
FundVantage Trust00 38,4470Abstain
AQR00 37,3340Abstain
Bridge Builder Trust31,5460 00For
John Hancock00 26,7350Abstain
CITY NATIONAL ROCHDALE FUNDS19,2100 00For
Invesco00 16,7110Abstain
Principal00 16,3280Abstain

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

4. Election of Directors: Cheryl L. Cohen

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.8% Majority: yes · of votes cast

FOR 99.8%
FOR: 561,728,022WITHHELD: 917,010

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Cheryl L. Cohen”): 561,728,022 for, 917,010 withheld, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 691,567,961 outstanding shares: 81% for, 0.2% withheld (81% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (3,001,607 for, 0 against).

FOR 95%
FOR: 3,001,607 (94.8%)ABSTAIN: 165,018 (5.2%)
Largest asset managers voting on “Election of Directors: Cheryl L. Cohen” at IMMUNITYBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street1,110,1980 2640For
WP Trust246,9880 00For
Vanguard234,7370 00For
Equitable174,8310 00For
Putnam00 163,9540Abstain
Charles Schwab139,0210 00For
Fidelity125,7320 00For
First Trust104,0900 00For
Lincoln Financial96,3000 00For
Amplify ETF Trust77,3240 00For
Principal Exchange-Traded Funds62,1150 00For
BlackRock61,2540 00For
Global X60,0600 00For
ProShares59,5120 00For
ETF Series Solutions58,4570 00For
Northern Trust55,9210 00For
Pacific Life45,0460 00For
Direxion Shares ETF Trust43,0640 00For
FundVantage Trust38,4470 00For
AQR37,3340 00For
Bridge Builder Trust31,5460 00For
John Hancock26,7350 00For
CITY NATIONAL ROCHDALE FUNDS19,2100 00For
Invesco16,7110 00For
Principal16,3280 00For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

5. Election of Directors: Richard Adcock

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 561,327,002WITHHELD: 1,318,030

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Richard Adcock”): 561,327,002 for, 1,318,030 withheld, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 691,567,961 outstanding shares: 81% for, 0.2% withheld (81% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (3,002,550 for, 0 against).

FOR 95%
FOR: 3,002,550 (94.8%)ABSTAIN: 164,075 (5.2%)
Largest asset managers voting on “Election of Directors: Richard Adcock” at IMMUNITYBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street1,110,3410 1210For
WP Trust246,9880 00For
Vanguard234,7370 00For
Equitable174,8310 00For
Putnam00 163,9540Abstain
Charles Schwab139,0210 00For
Fidelity125,7320 00For
First Trust104,0900 00For
Lincoln Financial96,3000 00For
Amplify ETF Trust77,3240 00For
Principal Exchange-Traded Funds62,1150 00For
BlackRock61,2540 00For
Global X60,0600 00For
ProShares59,5120 00For
ETF Series Solutions58,4570 00For
Northern Trust55,9210 00For
Pacific Life45,0460 00For
Direxion Shares ETF Trust43,0640 00For
FundVantage Trust38,4470 00For
AQR37,3340 00For
Bridge Builder Trust31,5460 00For
John Hancock26,7350 00For
CITY NATIONAL ROCHDALE FUNDS19,2100 00For
Invesco16,7110 00For
Principal16,3280 00For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

6. Election of Directors: Michael D. Blaszyk

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 561,317,164WITHHELD: 1,327,868

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Michael D. Blaszyk”): 561,317,164 for, 1,327,868 withheld, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 691,567,961 outstanding shares: 81% for, 0.2% withheld (81% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (2,767,813 for, 0 against).

FOR 87%13%
FOR: 2,767,813 (87.4%)ABSTAIN: 398,812 (12.6%)
Largest asset managers voting on “Election of Directors: Michael D. Blaszyk” at IMMUNITYBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street1,110,3410 1210For
WP Trust246,9880 00For
Vanguard00 234,7370Abstain
Equitable174,8310 00For
Putnam00 163,9540Abstain
Charles Schwab139,0210 00For
Fidelity125,7320 00For
First Trust104,0900 00For
Lincoln Financial96,3000 00For
Amplify ETF Trust77,3240 00For
Principal Exchange-Traded Funds62,1150 00For
BlackRock61,2540 00For
Global X60,0600 00For
ProShares59,5120 00For
ETF Series Solutions58,4570 00For
Northern Trust55,9210 00For
Pacific Life45,0460 00For
Direxion Shares ETF Trust43,0640 00For
FundVantage Trust38,4470 00For
AQR37,3340 00For
Bridge Builder Trust31,5460 00For
John Hancock26,7350 00For
CITY NATIONAL ROCHDALE FUNDS19,2100 00For
Invesco16,7110 00For
Principal16,3280 00For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

7. Election of Directors: John Owen Brennan

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.5% Majority: yes · of votes cast

FOR 99.5%
FOR: 560,173,170WITHHELD: 2,471,862

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: John Owen Brennan”): 560,173,170 for, 2,471,862 withheld, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 691,567,961 outstanding shares: 81% for, 0.4% withheld (81% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (2,998,303 for, 0 against).

FOR 95%
FOR: 2,998,303 (94.7%)ABSTAIN: 168,322 (5.3%)
Largest asset managers voting on “Election of Directors: John Owen Brennan” at IMMUNITYBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street1,110,1980 2640For
WP Trust246,9880 00For
Vanguard234,7370 00For
Equitable174,8310 00For
Putnam00 163,9540Abstain
Charles Schwab139,0210 00For
Fidelity125,7320 00For
First Trust104,0900 00For
Lincoln Financial96,3000 00For
Amplify ETF Trust77,3240 00For
Principal Exchange-Traded Funds62,1150 00For
BlackRock61,2540 00For
Global X60,0600 00For
ProShares59,5120 00For
ETF Series Solutions58,4570 00For
Northern Trust55,9210 00For
Pacific Life45,0460 00For
Direxion Shares ETF Trust43,0640 00For
FundVantage Trust38,4470 00For
AQR37,3340 00For
Bridge Builder Trust31,5460 00For
John Hancock26,7350 00For
CITY NATIONAL ROCHDALE FUNDS19,2100 00For
Invesco16,7110 00For
Principal16,3280 00For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

8. Election of Directors: Wesley Clark

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 560,587,816WITHHELD: 2,057,216

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Wesley Clark”): 560,587,816 for, 2,057,216 withheld, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 691,567,961 outstanding shares: 81% for, 0.3% withheld (81% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (3,001,607 for, 0 against).

FOR 95%
FOR: 3,001,607 (94.8%)ABSTAIN: 165,018 (5.2%)
Largest asset managers voting on “Election of Directors: Wesley Clark” at IMMUNITYBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street1,110,1980 2640For
WP Trust246,9880 00For
Vanguard234,7370 00For
Equitable174,8310 00For
Putnam00 163,9540Abstain
Charles Schwab139,0210 00For
Fidelity125,7320 00For
First Trust104,0900 00For
Lincoln Financial96,3000 00For
Amplify ETF Trust77,3240 00For
Principal Exchange-Traded Funds62,1150 00For
BlackRock61,2540 00For
Global X60,0600 00For
ProShares59,5120 00For
ETF Series Solutions58,4570 00For
Northern Trust55,9210 00For
Pacific Life45,0460 00For
Direxion Shares ETF Trust43,0640 00For
FundVantage Trust38,4470 00For
AQR37,3340 00For
Bridge Builder Trust31,5460 00For
John Hancock26,7350 00For
CITY NATIONAL ROCHDALE FUNDS19,2100 00For
Invesco16,7110 00For
Principal16,3280 00For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

9. Election of Directors: Linda Maxwell

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 561,368,993WITHHELD: 1,276,039

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Linda Maxwell, M.D.”): 561,368,993 for, 1,276,039 withheld, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 691,567,961 outstanding shares: 81% for, 0.2% withheld (81% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (2,767,813 for, 0 against).

FOR 87%13%
FOR: 2,767,813 (87.4%)ABSTAIN: 398,812 (12.6%)
Largest asset managers voting on “Election of Directors: Linda Maxwell” at IMMUNITYBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street1,110,3410 1210For
WP Trust246,9880 00For
Vanguard00 234,7370Abstain
Equitable174,8310 00For
Putnam00 163,9540Abstain
Charles Schwab139,0210 00For
Fidelity125,7320 00For
First Trust104,0900 00For
Lincoln Financial96,3000 00For
Amplify ETF Trust77,3240 00For
Principal Exchange-Traded Funds62,1150 00For
BlackRock61,2540 00For
Global X60,0600 00For
ProShares59,5120 00For
ETF Series Solutions58,4570 00For
Northern Trust55,9210 00For
Pacific Life45,0460 00For
Direxion Shares ETF Trust43,0640 00For
FundVantage Trust38,4470 00For
AQR37,3340 00For
Bridge Builder Trust31,5460 00For
John Hancock26,7350 00For
CITY NATIONAL ROCHDALE FUNDS19,2100 00For
Invesco16,7110 00For
Principal16,3280 00For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

10. Election of Directors: Christobel Selecky

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 561,329,841WITHHELD: 1,315,191

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Christobel Selecky”): 561,329,841 for, 1,315,191 withheld, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 691,567,961 outstanding shares: 81% for, 0.2% withheld (81% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (2,767,813 for, 0 against).

FOR 87%13%
FOR: 2,767,813 (87.4%)ABSTAIN: 398,812 (12.6%)
Largest asset managers voting on “Election of Directors: Christobel Selecky” at IMMUNITYBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street1,110,3410 1210For
WP Trust246,9880 00For
Vanguard00 234,7370Abstain
Equitable174,8310 00For
Putnam00 163,9540Abstain
Charles Schwab139,0210 00For
Fidelity125,7320 00For
First Trust104,0900 00For
Lincoln Financial96,3000 00For
Amplify ETF Trust77,3240 00For
Principal Exchange-Traded Funds62,1150 00For
BlackRock61,2540 00For
Global X60,0600 00For
ProShares59,5120 00For
ETF Series Solutions58,4570 00For
Northern Trust55,9210 00For
Pacific Life45,0460 00For
Direxion Shares ETF Trust43,0640 00For
FundVantage Trust38,4470 00For
AQR37,3340 00For
Bridge Builder Trust31,5460 00For
John Hancock26,7350 00For
CITY NATIONAL ROCHDALE FUNDS19,2100 00For
Invesco16,7110 00For
Principal16,3280 00For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

11. Election of Directors: Barry J. Simon, M.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.3% Majority: yes · of votes cast

FOR 99.3%
FOR: 559,237,600WITHHELD: 3,407,432

IMMUNITYBIO INC.’s own tally for this item (“Elect Director: Barry J. Simon, M.D.”): 559,237,600 for, 3,407,432 withheld, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 691,567,961 outstanding shares: 81% for, 0.5% withheld (81% of the company cast a for/withheld vote).

The 49 asset managers below cast 100% of the shares they voted on this item FOR (1,794,694 for, 0 against).

FOR 57%ABSTAIN 43%
FOR: 1,794,694 (56.7%)ABSTAIN: 1,371,931 (43.3%)
Largest asset managers voting on “Election of Directors: Barry J. Simon, M.D.” at IMMUNITYBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street2,7050 1,107,7570Abstain
WP Trust246,9880 00For
Vanguard234,7370 00For
Equitable174,8310 00For
Putnam00 163,9540Abstain
Charles Schwab139,0210 00For
Fidelity125,7320 00For
First Trust104,0900 00For
Lincoln Financial00 96,3000Abstain
Amplify ETF Trust77,3240 00For
Principal Exchange-Traded Funds62,1150 00For
BlackRock61,2540 00For
Global X60,0600 00For
ProShares59,5120 00For
ETF Series Solutions58,4570 00For
Northern Trust55,9210 00For
Pacific Life45,0460 00For
Direxion Shares ETF Trust43,0640 00For
FundVantage Trust38,4470 00For
AQR37,3340 00For
Bridge Builder Trust31,5460 00For
John Hancock26,7350 00For
CITY NATIONAL ROCHDALE FUNDS19,2100 00For
Invesco16,7110 00For
Principal16,3280 00For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

12. To ratify the selection of Ernst & Young LLP as ImmunityBio's independent registered public accounting firm for the fiscal year ending December 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Combines 4 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%
FOR: 606,920,437AGAINST: 2,216,896

IMMUNITYBIO INC.’s own tally for this item (“Proposal 4: Ratification of Appointment of Independent Registered Public Accounting Firm .”): 606,920,437 for, 2,216,896 against, per its Form 8-K filed 2024-06-12 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 691,567,961 outstanding shares: 88% for, 0.4% against (88% of the company cast a for/against vote).

The 49 asset managers below cast 98% of the shares they voted on this item FOR (3,089,114 for, 77,511 against).

FOR 98%
FOR: 3,089,114 (97.6%)AGAINST: 77,511 (2.4%)
Largest asset managers voting on “To ratify the selection of Ernst & Young LLP as ImmunityBio's independent registered public accounting firm fo” at IMMUNITYBIO INC., 2023-2024
Asset managerForAgainst AbstainWithheldVote
State Street1,110,275187 00For
WP Trust246,9880 00For
Vanguard234,7370 00For
Equitable174,8310 00For
Putnam163,9540 00For
Charles Schwab139,0210 00For
Fidelity125,7320 00For
First Trust104,0900 00For
Lincoln Financial96,3000 00For
Amplify ETF Trust077,324 00Against
Principal Exchange-Traded Funds62,1150 00For
BlackRock61,2540 00For
Global X60,0600 00For
ProShares59,5120 00For
ETF Series Solutions58,4570 00For
Northern Trust55,9210 00For
Pacific Life45,0460 00For
Direxion Shares ETF Trust43,0640 00For
FundVantage Trust38,4470 00For
AQR37,3340 00For
Bridge Builder Trust31,5460 00For
John Hancock26,7350 00For
CITY NATIONAL ROCHDALE FUNDS19,2100 00For
Invesco16,7110 00For
Principal16,3280 00For

Showing the 25 largest of 49 asset managers. See all 49 in the interactive database.

Largest IMMUNITYBIO INC. shareholders voting in 2023-2024

Ranked by the number of IMMUNITYBIO INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 691,567,961 shares outstanding at the time of that meeting.

Top IMMUNITYBIO INC. shareholders by shares voted, 2023-2024
#Asset manager % of shares outstanding
1State Street 0.53%
2JPMorgan 0.17%
3PERCEPTIVE ADVISORS LLC 0.11%
4Northern Trust 0.10%
5STIFEL NICOLAUS & CO INC \MO\ 0.09%
6BlackRock 0.08%
7Putnam 0.07%
8Charles Schwab 0.04%
9Vanguard 0.04%
10WP Trust 0.04%

Reported IMMUNITYBIO INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

IMMUNITYBIO INC. beneficial owners on record for the 2023-2024 proxy season
Holder % outstanding Disclosure
Patrick Soon-Shiong, M.D., FRCS (C), FACS 100.70% DEF14A
Nant Capital, LLC 42.18% DEF14A
Cambridge Equities, LP 37.84% DEF14A
California Capital Equity, LLC 15.40% DEF14A
NantWorks, LLC 14.25% DEF14A
NantMobile, LLC 6.88% DEF14A
Vanguard Group 4.00% 13F
BlackRock 2.86% 13F
State Street 2.05% 13F
Barry J. Simon, M.D. 0.58% DEF14A

Percentages above are of 691,567,961 shares outstanding, as reported by IMMUNITYBIO INC. on its Form 10-Q dated 2024-05-03 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from IMMUNITYBIO INC.’s 10-Q dated 2024-05-03. This page is a static snapshot rebuilt weekly on 04 October 2026; a live search always shows the current data.

At IMMUNITYBIO INC.'s shareholder meeting held 2024-06-11, in the 2023-2024 proxy season, 164 asset managers reported how they voted on 12 ballot items in their SEC Form N-PX filings, covering 1,736 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory (non-binding) basis, the compensation of our Named Executive… — the proposal passed with 99.5% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: IMMUNITYBIO INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on 2024-06-12.

IMMUNITYBIO INC. proxy season coverage: 2023-2024 (this page).